TECCHIO, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 7.756
EU - Europa 6.971
AS - Asia 4.933
SA - Sud America 683
AF - Africa 125
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
Totale 20.489
Nazione #
US - Stati Uniti d'America 7.616
RU - Federazione Russa 2.536
SG - Singapore 1.876
CN - Cina 1.477
GB - Regno Unito 1.459
IT - Italia 759
BR - Brasile 545
DE - Germania 531
VN - Vietnam 451
HK - Hong Kong 406
SE - Svezia 380
FR - Francia 363
IE - Irlanda 304
FI - Finlandia 267
KR - Corea 145
JP - Giappone 124
IN - India 102
UA - Ucraina 88
CA - Canada 85
BD - Bangladesh 68
ES - Italia 58
AR - Argentina 52
TR - Turchia 46
ID - Indonesia 44
IQ - Iraq 43
PL - Polonia 43
NL - Olanda 38
BE - Belgio 35
AT - Austria 30
MX - Messico 30
NG - Nigeria 30
PK - Pakistan 30
ZA - Sudafrica 29
IR - Iran 20
VE - Venezuela 17
CO - Colombia 15
CL - Cile 14
MA - Marocco 13
CH - Svizzera 12
EC - Ecuador 12
PY - Paraguay 12
UZ - Uzbekistan 12
KE - Kenya 11
PH - Filippine 11
AU - Australia 9
JO - Giordania 9
TN - Tunisia 9
BJ - Benin 8
LT - Lituania 8
AZ - Azerbaigian 7
IL - Israele 7
PE - Perù 7
RO - Romania 7
CZ - Repubblica Ceca 6
JM - Giamaica 6
MY - Malesia 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
DK - Danimarca 5
EG - Egitto 5
HR - Croazia 5
NP - Nepal 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
CR - Costa Rica 4
DZ - Algeria 4
EU - Europa 4
NO - Norvegia 4
OM - Oman 4
PA - Panama 4
PT - Portogallo 4
RS - Serbia 4
TG - Togo 4
UY - Uruguay 4
BO - Bolivia 3
GR - Grecia 3
HN - Honduras 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
PS - Palestinian Territory 3
TH - Thailandia 3
BB - Barbados 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GT - Guatemala 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
MZ - Mozambico 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 20.466
Città #
Southend 1.228
Ashburn 1.067
Dallas 1.021
Singapore 1.011
Moscow 883
Chandler 705
San Jose 669
Jacksonville 577
Hong Kong 399
Woodbridge 391
Verona 332
Ann Arbor 327
Dublin 299
Beijing 252
Houston 216
The Dalles 172
Council Bluffs 158
New York 148
Ho Chi Minh City 138
Los Angeles 123
Wilmington 114
Jinan 112
Lawrence 108
Princeton 108
Munich 97
Hanoi 86
Nanjing 86
Shenyang 81
Milan 75
Hebei 69
Buffalo 61
São Paulo 61
Santa Clara 58
Tokyo 55
Helsinki 54
Turku 53
Tianjin 51
Changsha 48
Redondo Beach 43
Sindelfingen 41
Frankfurt am Main 39
Orem 38
Columbus 37
London 37
Nanchang 36
Boardman 35
Warsaw 35
Brussels 34
Dong Ket 33
Chennai 32
Guangzhou 32
Ningbo 32
Taizhou 32
Zhengzhou 32
Haikou 30
Seattle 30
Taiyuan 30
Jakarta 29
Madrid 29
Hangzhou 28
Montreal 28
Abuja 27
Stockholm 27
Chicago 26
Jiaxing 25
Bologna 24
San Francisco 24
Baghdad 23
Brooklyn 23
Dearborn 23
Redmond 23
Seoul 23
Toronto 23
Denver 22
Haiphong 22
Rome 22
Johannesburg 21
Kent 21
Belo Horizonte 20
Fuzhou 20
Lappeenranta 20
Norwalk 18
Phoenix 18
Atlanta 17
Lanzhou 17
Paris 17
Düsseldorf 16
Manchester 16
Nuremberg 16
Redwood City 16
Shanghai 16
Vienna 16
Lancaster 15
Nürnberg 15
San Giovanni Lupatoto 15
Brasília 14
Poplar 14
Rio de Janeiro 14
Da Nang 13
Fairfield 13
Totale 13.020
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 459
Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation 436
Acute lymphoblastic leukemia (ALL) in elderly patients receiving intensive treatment. Experience in 26 consecutive patients 269
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients 269
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 262
CD66b-CD64dimCD115- cells in the human bone marrow represent neutrophil-committed progenitors 255
Down-regulation of protein tyrosine phosphatase gamma (PTPRG) in chronic myeloid leukemia (CML) 249
NEUROLOGICAL COMPLICATIONS IN ADULT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: RESULTS FROM A RETROSPECTIVE MULTICENTRE STUDY 246
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma 244
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 243
Protein Tyrosine Phosphatase Receptor Type γ Is a Functional Tumor Suppressor Gene Specifically Downregulated in Chronic Myeloid Leukemia 239
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 239
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 239
A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma 237
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 233
HB-EGF/HER -1 SIGNALLING IN BONE MARROW MESENCHYMAL STEM CELLS: INDUCING CELL EXPANSION AND PREVENTING REVERSIBLY MULTI-LINEAGE DIFFERENTIATION 232
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 231
A novel large-sized BCR-ABL transcript in a case of chronic myeloid leukaemia characterised by a favourable clinical course. 227
ANTI-MÜLLERIAN HORMONE AND ANTRAL FOLLICLE COUNT REVEAL A LATE IMPAIR- MENT OF OVARIAN RESERVE IN PATIENTS UNDERGONE LOW GONADOTOXIC REGIMENS FOR HAEMATOLOGICAL MALIGNANCIES 227
Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells 217
Erectile Dysfunction after Allogeneic Hematopoietic Stem Cell Transplant: Results from a Single Center Experience 215
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 213
Neutrophil-derived cytokines: facts beyond expression 211
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 211
Cellular antigens and soluble molecules and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 206
Unusual case of solitary intraparenchymal brain plasmacytoma. 201
A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature 199
Effects of sodium selenite on in vitro interactions between platelets and endothelial cells 198
Synthetic PGI-2 (Iloprost) treatment in patients with resistant sclerodermic chronic GVHD (cGVHD) after Allogeneic Hematopoietic Stem Cell Transplantation 198
Bone marrow mesenchymal stem cells express HER-1 and are sensitive to the effect of HB-EGF 197
Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin 195
Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies 195
Human neutrophils in the saga of cellular heterogeneity: insights and open questions. 195
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 195
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 195
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 193
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 193
CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. 191
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 190
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 189
Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome 186
Ataluren improves hematopoietic and pancreatic disorders in Shwachman-Diamond syndrome patients: a compassionate program case-series 184
Clinical and experimental efficacy of gemtuzumab ozogamicin in core binding factor acute myeloid leukemia 183
Utility of anti-mullerian hormone for the evaluation of fertility preservation in female patients after chemotherapy [Determinazione dell'ormone anti-mulleriano per la valutazione della riserva ovarica in pazienti dopo trattamento chemioterapico] 183
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 181
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study 181
Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. 179
Anti-Müllerian hormone and antral follicle count reveal a late impairment of ovarian reserve in patients undergoing low-gonadotoxic regimens for hematological malignancies 177
Correlation between clinical features and circulating levels of soluble intercellular adhesion molecule-1 in Hodgkin's disease 176
Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 granulocytopenic patients with hematological malignancies 175
Efficient lysis of B-chronic lymphocytic leukemia cells by the plant-derived sesquiterpene alcohol α-bisabolol, a dual proapoptotic and antiautophagic agent 174
Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: no differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol 171
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 171
Function analysis of estrogenically regulated protein tyrosine phosphatase gamma (PTPgamma) in human breast cancer cell line MCF-7. 169
Allogeneic stem cell transplantation in patients with mantle cell lymphoma: results from the MANTLE-FIRST study on behalf of Fondazione Italiana Linfomi 169
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 169
Uncovering two neutrophil-committed progenitors that immediately precede promyelocytes during human neutropoiesis 166
Motility analysis of pancreatic adenocarcinoma cells reveals a role for the atypical zeta isoform of protein kinase C in cancer cell movement 166
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 162
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors 160
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 160
Antimicrobial resistance of Gram-negative bacteria isolated from blood in HSCT patients: a multinational prospective study on behalf of the EBMT-IDWP. 159
Receptor-type protein tyrosine phosphatase gamma (PTPgamma), a new identifier for myeloid dendritic cells and specialized macrophages 158
HB-EGF/HER-1 signaling in bone marrow mesenchymal stem cells: inducing cell expansion and reversibly preventing multilineage differentiation 158
The cross-talk between myeloid and mesenchymal stem cells of human bone marrow represents a biomarker of aging that regulates immune response and bone reabsorption 158
Long-term persistence of molecular response after discontinuation of interferon-alpha in two patients with chronic myeloid leukaemia 157
Functional dosing of mesenchymal stromal cell-derived extracellular vesicles for the prevention of acute graft-versus-host-disease 157
Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. 155
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia 153
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up. 153
Monocentric Analysis of the Effectiveness and Financial Consequences of the Use of Lenograstim Versus Filgrastim for Mobilization of Peripheral Blood Progenitor Cells in Patients With Lymphoma and Myeloma Receiving Chemotherapy and Autologous Stem Cell Transplantation 153
Long-term remissions with Gilteritinib in early relapse after allogeneic stem cell transplantation of FLT3/NPM1 mutated acute myeloid leukemia 150
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance 148
High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma 145
Relationship between Daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia 144
Concomitant chronic lymphocytic leukemia and acute myeloid leukemia: evidence of simultaneous expansion of two independent clones 144
Hyperchidam Verona897 Regimen Is Effective in Treatment of Advanced Peripheral T Cell Lymphoma (PTCL): The GITIL Experience in 33 Cases 143
Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia 141
Rapid Response and Containment of an NDM-Producing Klebsiella Pneumoniae Outbreak in a Hematology Ward: Case Study from an Italian Hospital 140
Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome 140
Idiopathic hypereosinophilic syndromes and rare dysimmune conditions associated with hyper-eosinophilia in practice: An innovative multidisciplinary approach 139
Predictors of anxiety and depression in hematopoietic stem cell transplant patients during protective isolation. 139
Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma 138
PBX/E2A transcript positive B-lymphoblastic leukemia (B-ALL) presenting with bilateral renal and myocardial involvement: a case report. 137
Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators. 132
HER-1 Transactivation by monocyte and cancer cell 7-TMD receptors 130
Membrane and soluble antigens and cytokine receptors in leukemia and lymphoma: biological role and clinical applications 129
On the persistence of the primitive chronic myeloid leukaemia cell in patients in complete molecular response 127
IMMUNE THROMBOCYTOPENIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: CASE REPORT AND BRIEF OVERVIEW OF TREATMENT STRATEGIES 126
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 124
Rituximab-CHOP or two-weekly CHOP +G-CSF in aggressive lymphoma of the ederly ? 124
Primary mediastinal large B-cell lymphoma (PML-BCL):long term results from a retrospective multicentre Italian experience in 138 patients treated with CHOP or MACOP-B/VACOP-B 123
Invasive aspergillosis in neutropenic patients: rapid neutrophil recovery is a risk factor for severe pulmonary complications 122
On the Cytokines Produced by Human Neutrophils in Tumors. 122
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death 122
IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells. 121
HB-EGF/HER -1 signalling in bone marrow mesenchymal stem cells: inducing cell expansion and preventing reversibly multi-lineage differentiation 119
Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897) 119
Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice 118
SIMILAR BUT NOT THE SAME: CHROMOSOMAL ABNORMALITIES T(8;21)(Q22;Q22) AND INV(16)(P13;Q22)/T(16;16)(P13;Q22) IDENTIFY SUBTYPES OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA CHARACTERIZED BY DIFFERENT SURVIVAL AND PROGNOS- TIC FACTORS 117
Totale 18.259
Categoria #
all - tutte 65.798
article - articoli 54.169
book - libri 0
conference - conferenze 11.118
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 511
Totale 131.596


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202166 0 0 0 0 0 0 0 0 0 0 0 66
2021/20221.052 73 300 5 78 45 20 17 55 41 116 105 197
2022/20231.957 141 197 164 363 173 495 13 126 216 12 35 22
2023/20241.267 39 89 87 98 91 179 65 315 9 50 167 78
2024/20252.832 152 142 116 464 118 102 162 123 408 163 338 544
2025/20269.021 540 848 694 1.409 2.117 566 811 455 705 530 168 178
Totale 20.677